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m.2012.0Abstract Activity of small bowel inﬂammatory disease, mainly Crohn’s disease had traditionally
been a challenging task for radiologists and gastroenterologists. Conventional radiologic and endo-
scopic evaluations are frequently hindered by the length and caliber of small bowel loops. Conven-
tional CT plays a signiﬁcant role in the evaluation of extraenteric manifestations of small bowel
disease, although it has a limited role for depicting bowel wall and luminal abnormalities. With
the development of CT enterography, evolving new methods for evaluating the small bowel mucosal
and submucosal abnormality were considered a byproduct of the recent advances in multidetector-
row CT (MDCT) technology. Endoscopic correlation with imaging modalities are complementary
tools for the ﬁnal diagnosis of activity and complications of Crohn’s disease.
Our purpose was to evaluate retrospectively the effectiveness of CT enterography for the assessment
of the activity as well as diagnosing complications of Crohn’s disease in 25 patients with a comple-
mentary role determined by colonoscopy with intubation of the terminal ileum and correlate with
disease progression or regression and its treatment.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Crohn’s disease is a trans-mural inﬂammatory process that can
extend to surrounding peri-enteric fat and mesentery and com-03 5459009; fax: +20 203
(A.H. Aﬁﬁ).
tian Society of Radiology and
g by Elsevier
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7.004monly affect the small bowel in 70% of the patients where 1/3
of these cases show lesions limited to the ileum (1).
The classic clinical presentations of Crohn’s disease include
abdominal pain, diarrhea, and weight loss, usually following a
chronic relapsing course, with individual differences in the type
and severity of symptoms (2). Complications include bleeding,
obstruction, strictures, abscesses, and ﬁstula formation (2,3).
In the past, radiological diagnosis of Crohn’s disease in the
small bowel was via barium examinations with conﬁrmation of
the diagnosis using endoscopy. Conventional endoscopy,
although providing a direct view of the mucosal surface, is lim-
ited to the proximal small bowel or to the distal terminal ileum
(in which case it is termed ileoscopy). Ileoscopy is furtherProduction and hosting by Elsevier B.V.Open access under CC BY-NC-ND
 license.
508 A.H. Aﬁﬁ, M.I. Kassemcompromised by the occasional inability to reach the cecum or
intubate the ileum during colonoscopy (4).
Although barium small bowel follow-through can effec-
tively depict transmural disease, it may be hindered for depict-
ing mild or early disease, such as aphthous ulcers or other
subtle mucosal abnormalities, in such cases direct visualization
of the mucosal surface using endoscopy is crucial (4).
Newer techniques, such as capsule endoscopy and multi-
detector computed tomography (MDCT) enterography, have
the ability to provide a complete small-bowel evaluation. CT
enterography has the ability to depict subtle ﬁndings in Cro-
hn’s disease such as mucosal hypervascularity or mild wall
thickening, which are not depicted by standard barium exam-
inations. Also evaluation of the surrounding mesenteric fat
planes for stranding and fat proliferations and the assessment
of enlarged draining lymph nodes is evaluated superiorly with
CT enterography (5,6).
Computed tomography (CT) has traditionally been used to
assess extra-enteric complications such as abscess, ﬁstula, or
obstruction. Additionally, CT is a promising tool in the assess-
ment of the disease activity and follow up after initial treat-
ment (7).Fig. 1 Coronal CECT showing typical features of Crohn’s
disease as enhanced thickened mucosa, submucosal edema (mural
stratiﬁcations), extraenteric fatty proliferation (Creeping fat sign)
and engorged mesenteric LN.(Comb’s sign).2. Materials and methods
Fifty CT enterography examinations done for 25 patients with
known or suspected Crohn’s disease were retrospectively eval-
uated by a radiologist who was blinded to the clinical history.
The examined patients who agreed to participate in the study
and provided with informed consent (met the study criteria)
were enrolled. There were 15 women and 10 men; their ages
ranged from 20 to 55 years (mean, 45.2 years) who were re-
ferred to the outpatient clinic of GIT surgical department then
subsequently referred to the Radiology Department in the
Main University Hospital of Alexandria, Faculty of Medicine.
One radiologist determined whether imaging ﬁndings of
Crohn’s disease were present and, if so, whether the ﬁndings
progressed, regressed, or remained stable with consecutive fol-
low up examinations. CT enterography ﬁndings were then
compared with disease progression or regression based on
symptoms and clinical follow up. Direct comparison of CT
enterography and endoscopy was also performed.
Inclusion criteria: included a known or suspected diagnosis
of Crohn’s disease based on pathologic or endoscopic ﬁndings,
consent from all patients to use medical records for research,
ileo-colonoscopy with intubation of the terminal ileum, age
of at least 18 years, and two contrast-enhanced CT enterogra-
phy examinations between March 2009 and March 2012, and a
minimum 2-week clinical follow-up after the second CT
enterography.
Exclusion criteria: included pregnancy, renal insufﬁciency
(high serum creatinine levels of 2 mg/dl or greater), and docu-
mented reaction to iodinated contrast material.
2.1. CT enterography technique
All patients who underwent CT enterography were used to
taking nothing by mouth for 6 h before scanning, then ingested
a total of 1,350 mL of oral water as a neutral contrast material
mixed with mannitol (sorbitol) over a 60-min period as
follows:s Four hundred and ﬁfty milliliters during the ﬁrst and sec-
ond 20 min (60,40 min before scanning) then 225 mL during
the third 20 min (20 min before scanning) and lastly 225 mL
on CT table.
Patients were scanned on a 16-MDCT scanner (Sensation
16, Siemens Medical Solutions). Glucagon (0.5 mg) was given
IV immediately before scanning, and 150 mL of IV contrast
material (iohexol; Omnipaque, GE Healthcare) was given at
a rate of 4 mL/s. Single-phase scanning during the enteric
phase was performed after a 45-s delay. Section thickness used
was 3 mm and the reconstruction interval was 1.5 mm. Coro-
nal reconstructions were performed at 3-mm-thick sections
every 3 mm.
One radiologist with expertise in abdominal imaging, who
was blinded to presenting symptoms and endoscopic results,
reviewed all CT enterography exams and recorded any imag-
ing ﬁndings of Crohn’s disease that were present in the small
bowel or colon.
Findings consistent with Crohn’s disease included mucosal
hyperenhancement, bowel wall thickening >3 mm or compli-
cations such as bowel strictures, ﬁstula, or abscess. While still
blinded to clinical history and endoscopy results, the same
radiologist then compared CT enterography examinations
for each patient to determine whether imaging ﬁndings pro-
gressed, regressed, or remained stable between examinations.
The location of the disease was also recorded (colon, small bo-
wel, or both).
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active Crohn’s disease included mucosal hyperenhancement,
mural stratiﬁcation, and mesenteric fat proliferations, strand-
ing and engorged vasa rectae (Comb’s sign). Mucosal hyper-
enhancement was deﬁned radiologically as segmental hyperat-
tenuation of the bowel wall (when absent mural stratiﬁcation)
compared with other normal loops or of enhanced inner aspect
(mucosa) of the bowel wall (when present mural stratiﬁcation).
Figs. 1–3.
Comparison must be between bowel loops of the same re-
gion as well as of same degree of distention.
Endoscopic small bowel examination criteria determining
active Crohn’s disease included aphthous ulcers, fold thicken-
ing, linear ulcers and cobblestone pattern, and luminal stenosis
with ulceration.
2.2. Interpretation of the MDCT enterography images
Axial images better to assess closely apposed small bowel loops
and inter-loop abscesses,Fig. 2 A,B axial CECT and C sagittal CECT) revealed (A) sure signs
increased wall thickness of affected segment 6 mm, and (C) engorgedCoronal images allowed a global view of the small bowel,
helped to identify the terminal ileum and assess the length of
involved segments and may help to identify and localize
ﬁstulas,
Sagittal images particularly helpful in evaluating the rectum
and in detecting ﬁstulas,
Coronal maximum intensity projections are helpful for visu-
alizing perienteric mesenteric stranding and engorged vasa rec-
ta, and for evaluating vascular structures.
2.3. Clinical symptoms and follow-up
We used an electronic clinical database to record the present-
ing symptoms at the ofﬁce visit before each CT enterography.
Symptoms included abdominal pain, diarrhea, rectal bleeding,
weight loss, nausea, and fever. A gastroenterologist with exper-
tise in inﬂammatory bowel disease, who was blinded to CT
enterography results, reviewed the clinical notes to determine
whether symptoms had progressed, regressed, or remainedof activity as attenuation value of enhancing mucosa 120 HU, (B)
mesenteric vessels and reactive adenopathy.
Fig. 3 Axial contrast enhanced fat suppression MRI revealed
bilateral saddle shape perianal ﬁstula with acutely inﬂamed
enhancing margins. The shape of ﬁstula and bilateral involvement
is characteristic of Crohn’s disease.
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ond CT enterography examination was also performed using
the electronic clinical note database. Interval changes in Cro-
hn’s disease treatment, symptoms, and the length of follow-
up were recorded.
2.4. Endoscopy
All the 25 patients underwent endoscopy with intubation of
the terminal ileum. A gastroenterologist with expertise in
IBD reviewed all endoscopic examination reports and images
to identify ﬁndings consistent with Crohn’s disease. The mean
time between CT enterography and ileoscopy was 4.2 days
with a range of 0–30 days.
Twenty-one patients underwent terminal ileum biopsy and
conﬁrmed histopathologically. The other four patients had
negative endoscopic results and hence did not undergo biopsy.
In these patients, endoscopic assessment of the terminal ileum
was used as the reference standard for the presence of active
small bowel inﬂammation.
Because some histologic and endoscopic ﬁndings are non-
speciﬁc for Crohn’s disease, a panel of three gastroenterolo-
gists (C.A.S., E.V.L., and W.J.S. with 2, 9, and 11 years of
subspecialty experience, respectively, in IBD) created a com-
bined histologic and endoscopic reference standard. When
biopsy of the terminal ileum was not performed, only endo-
scopic assessment of the terminal ileum was used. One of the
gastroenterologists (C.A.S.) reviewed the written pathology
and ileoscopy reports to categorize patients into one of three
groups: patients with deﬁnitely active Crohn’s disease, patients
with probable active Crohn’s disease and lastly patients without
Crohn’s disease.
Deﬁnitely active Crohn’s disease cases had either chronic
ileitis, or acute ileitis, which was diagnosed histologically in
conjunction with ulceration, stenosis, or erosions that were evi-
dent at endoscopy.
Probable active Crohn’s disease cases had several combina-
tions of histologic and endoscopic ﬁndings, including (a)
chronic ileitis at histologic analysis and normal endoscopicresults, (b) normal histologic ﬁndings but stenosis, ulceration,
granularity, or friability at endoscopy, or (c) acute ileitis at his-
tologic analysis, with granularity, friability, or erythema at
endoscopy.
Eight patients subsequently underwent surgery with a mean
time between CT and surgery of 18.4 days and a median of
21 days (Table 1, Figs. 4–11).
2.5. Data analysis
Changes in symptoms and CT ﬁndings were quantiﬁed either
by progression, stability, or regression. The agreement of the
change in CT ﬁndings versus symptoms was measured using
the weighted kappa coefﬁcient.
The percentage of CT enterography ﬁndings that agreed
with symptoms overall and for each category (progression,
regression, stable) was reported. The percentage of CT enter-
ography ﬁndings that agreed with endoscopic ﬁndings was also
reported. The statistical uncertainty of the percentages was
quantiﬁed using the exact binomial method.
2.6. Statistical analysis
The mean maximal mural attenuation values for the distended
jejunum and distended ileum were compared. Mural hyperen-
hancement was the most sensitive CT ﬁnding of active Crohn’s
disease. The degree of bowel wall enhancement correlates with
the severity of active inﬂammation and is used to monitor anti-
inﬂammatory therapy.
Mural stratiﬁcation is visualization of the bowel wall layers
on CT after IV contrast. Edematous bowel wall usually has a
trilaminar appearance on CT enterography (‘‘target’’ sign): an
internal ring of mucosal enhancement, an external ring of sero-
sal and muscular enhancement, and an interposed submucosal
layer with decreased attenuation. In chronic IBD, fat deposi-
tion may be seen in the submucosa and should not be confused
with the mural stratiﬁcation that is seen with acute disease.
Comparisons were made by using a Student t test, with P
values of <0.05 indicating a statistically signiﬁcant difference.
AX2 analysis was used to determine differences in the grades of
distention by using pair wise comparisons between the jeju-
num, ileum, and terminal ileum and between patients with
Crohn’s disease and those without Crohn’s disease for each
bowel segment.
3. Results
Disease progression or regression by CT enterography corre-
lated with symptoms in 20 of 25 (80%) patients. Speciﬁcally,
CT enterography and symptoms agreed in 15 patients with
clinical disease progression, three patients with clinical regres-
sion, and two with clinically stable disease. In ﬁve of 25 pa-
tients (20%), symptoms progressed although CT
enterography ﬁndings were improved (n= 3) and negative
(n= 2) {at follow-up, four of the ﬁve patients improved and
the remaining patient was stable symptomatically}.
Twenty-ﬁve ileoscopies were attempted in the 25 patients;
all examinations reached the terminal ileum. Endoscopy ﬁnd-
ings correlated with CT enterography ﬁndings in most of the
cases (24/25, 96%, i.e., positive endoscopy ﬁndings of Crohn’s
disease and positive CT enterography ﬁndings of Crohn’s
Table 1 Summary of operative intervention in 8 patients with Crohn’s disease complications. (Fig. 4–11).
Site of the
disease
Indications of surgery Operative procedures Follow up
Jejunum
(Fig. 4)
Massive lower GI bleeding
with Hemoglobin (HB) 4 gm
Resection and anastomosis Marvelous response, HB
rises to 11gm, good
response conﬁrmed by CT
Terminal
ileum (Fig. 5)
Intestinal obstruction due to
distal ileal stricture
Limited resection and
anastomosis
Good response conﬁrmed
by CT enterography
Terminal
ileum and
cecum
(Fig. 6)
Attacks of Intestinal
obstruction, Suspicion of
tumor with associated
appendicitis
Right hemicolectomy including
appendectomy
Good response conﬁrmed
by CT enterography
Ileum (Fig. 7) Anemia and adhesions Limited three resections and
anastomosis
Good response conﬁrmed
by CT enterography
Distal Ileum
(Fig. 8)
Fistulation with UB with
bleeding
Fistula closure and resection
anastomosis
Good response conﬁrmed
by CT enterography
Left colon
(Fig. 9)
Adhesion and ileocolic ﬁstula Limited resection and
anastomosis of ileum with ﬁstula
(arrow) and left hemicolectomy
Good response by CT
enterography and
colonoscopy
Right colon
(Fig. 10)
Large abscess formation with
extension to iliacus muscles
Drainage followed with right
hemicolectomy
Good response conﬁrmed
by CT enterography
Right colon
(Fig. 11)
Ulceration and phlegmon
adherent to UB
Drainage then RT
hemicolectomy
Improved, conﬁrmed with
CT enterography
Fig. 4 A,B Intraoperative photographs for a 22-year-old female
presented with massive lower gastrointestinal bleeding due to
jejunal Crohn’s disease, the affected jejunal segment with Crohn
disease (A), and associated with mesenteric LNs (B). Resection
and anastomosis of the limited jejunal segment was done.
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cases (25/25,100%).
Endoscopy showed inﬂammatory lesions in the 20 patients
(mild disease, four; moderate disease, six; and severe disease,10 patients). The endoscopist assigned grades to severity at
endoscopy according to the score of Rutgeerts et al. (8) in pa-
tients who had previously undergone surgery.
For the other patients, they assigned grades to severity
according to the Simple Endoscopic Score for Crohn’s Dis-
ease, as stipulated by Daperno et al. (9), as follows: normal
grade, no lesions; mild grade, aphthous lesions with normal
mucosa between them or nonobstructing stenosis; moderate
grade, diffuse aphthae; or severe grade, diffuse inﬂammation
with large ulcers (>2 cm), nodules, or stricture with inability
to intubate the terminal ileum. For the purpose of statistical
analysis, normal and mild grades at endoscopy were grouped
and were considered as inactive disease, and moderate and se-
vere grades at endoscopy were considered as active disease.
3.1. Radiological signs of Crohn’s activity
Mural thickening greater than 3 mm in a distended bowel loop
correlated highly with disease activity and, was present in up to
82.5% of patients, it was the most frequently observed CT
ﬁnding in Crohn’s disease. When associated with mural hype-
renhancement, increased attenuation of the mesenteric fat is
due to edema and engorgement of the vasa recta and is the
most speciﬁc CT ﬁnding for active Crohn’s disease.
CT enterography enabled correct identiﬁcation of terminal
ileum in all examined patients. The mentioned CT criteria for
diagnosing active disease were good predictors of active small
bowel disease at ileoscopy. Additionally, CT enterography is
more sensitive in the detection of extraenteric complications
such as abscesses and ﬁstulas.
The performance of CT enterography in depicting Crohn’s
disease in patients with endoscopic and pathologic evidence of
active terminal ileal disease was high as CT enterography cor-
rectly demonstrated active ileal Crohn’s disease in 20 of the 25
patients. Active disease was demonstrated by mucosal hype-
renhancement (n= 14), mural stratiﬁcation (n= 4), or mesen-
teric fat stranding (n= 2).
Fig. 5 A forty-year-old male patient presented with recurrent attacks of small intestinal obstruction due to Crohn disease of the terminal
ileum, A, B axial and coronal CECT revealed long segment of stricture with enhancing thick mucosa, submucosal edema and dilated small
bowel proximal to obstruction . C, D Surgical specimens reveal segmental Crohn disease of the terminal ileum treated with limited
resection and anastomosis.
Fig. 6 A ﬁfty-year-old female patient presented with small intestinal obstruction and bleeding, A. Sagittal oblique CECT revealed
stricture at distal ileum and caecum due to active Crohn’s disease associated with acute appendicitis. B, C, D surgical specimens reveal
segmental Crohn’s disease of the ileum and caecum (highly suspicion of tumor), and associated appendicitis treated with right
hemicolectomy.
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Fig. 7 A forty-two-year-old female patient presented with small
intestinal stricture and adhesions causing bleeding and anemia,
multiple limited resections and anastomosis was done; surgical
resection specimens reveal Crohn’s disease of the ileum (arrows).
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objectively correlate mural hyper-enhancement and wall thick-
ness with disease activity. Using a mural attenuation threshold
of 109 HU and an abnormal-to-normal loop enhancement ra-
tio of more than 1.3, CT enterography is highly correlated with
histologic ﬁndings of activity.
3.2. Endoscopic signs of Crohn’s activity
The most common ﬁndings at endoscopy were erosions
(n= 12), ulcers (n= 8), stricture (n= 4) and pseudopolyps
(n= 1). On the basis of endoscopy, two false-negative CT
enterography studies for colon disease were found at endos-
copy. There were two false-positive CT enterography examin-
ations (suspected disease in the terminal ileum in one patient,
the colon in another).
The mean time between CT enterography examinations was
11.8 ± 7.0 months (median, 6 months; range, 1–22 months).
The mean time between clinical examinations was
12 ± 5.4 months (median, 6 months; range, 1–19 months),
nearly identical to the time between CT enterography examin-
ations. The mean time between clinical evaluations before CT
enterography was 6 days (range, 0–44 days). The average time
of clinical follow-up was 12 weeks (range, 1–13 weeks).
3.3. Radiology of chronicity and complications of Crohn’s
disease
In chronic Crohn disease, mural stratiﬁcation may be absent
because of the transmural ﬁbrosis, leading to a homogeneous
and less-intense enhancement. Other signs include submucosal
fat deposition, sacculations, ﬁbrofatty proliferation, and
stricturesComplications were detected radiologically in the form of
ﬁstulas (3 cases), sinus tracts (one case), abscesses (two cases)
and phlegmons (one patient). Fistulas on CT enterography
seen as enhancing tracts extend from the bowel to other struc-
tures. Sinus tracts had a similar appearance but did not extend
to other structures. Abscesses seen as circumscribed extralumi-
nal ﬂuid collections with enhancing, well-deﬁned walls and
phlegmons were deﬁned as extraenteric masses of ﬂuid and
soft-tissue attenuation
3.4. Correlated symptoms with CT enterography
Twenty patients with concordant symptoms and CT enterog-
raphy, most had evidence of worsening disease (15/20, 75%).
Imaging ﬁndings at CT enterography included bowel wall
thickening with mucosal hyper-enhancement, (n= 33 examin-
ations), ﬁstula (n= 4), abscess (n= 5), adhesions (n= 2) and
bowel obstruction (n= 3). For patient symptoms, abdominal
pain was the most common complaint (n= 20), followed by
diarrhea (n = 9), rectal bleeding (n= 4), and nausea
(n= 5). Some patients presented with more than one
complaint.
Most (12/15) patients with worsening ﬁndings on CT enter-
ography received additional treatment for Crohn’s disease.
These patients showed symptomatic improvement at follow
up with changes in Crohn’s disease medical therapy (n= 5)
and surgery (n= 7). US guided percutaneous drainage of ab-
scess for three patients was done and no treatment was given
for the other two patients who had no change in the symptoms.
Two patients with concordant symptoms and CT enterog-
raphy had evidence of disease regression. The two patients
with improving symptoms (resolution of gastrointestinal
bleeding) were imaged to exclude other causes of bleeding.
CT enterography in these patients showed resolution or de-
crease in colonic wall thickening and enhancement. One pa-
tient underwent initial endoscopy conﬁrming disease in the
colon and conﬁrms resolution. At follow-up, however, both
patients were asymptomatic.
Two patients with concordant symptoms and CT enterog-
raphy showed no change in either symptoms or imaging ﬁnd-
ings. These patients were imaged because of continued
diarrhea despite treatment and to follow-up suspected bowel
strictures in the absence of symptoms. At CT enterography,
one patient had stable thickening of the terminal ileum and
the other remained negative. None of the patients with stable
CT enterography ﬁndings received additional treatment for
Crohn’s disease, and both were stable at follow-up.
3.5. Uncorrelated symptoms with CT Enterography
Discordant CT enterography ﬁndings and symptoms were
present in ﬁve of 25 (20%) patients. Four patients had worsen-
ing symptoms of pain but by CT enterography was improved.
One patient with improved CT enterography had undergone
interval resection of the diseased small bowel, and the others
had decreased wall thickening and enhancement of the ileum.
One endoscopy was performed at the time of the second CT
enterography in the patients with ileal disease, which showed
ileal erosions only (the initial endoscopy showed active Cro-
hn’s disease). At follow-up, the patients were asymptomatic
without any change in Crohn’s disease therapy. The patient
Fig. 8 (A and B) coronal CECT demonstrating entero-vesical
ﬁstula with Catheter seen passing from UB lumen to enter bowel
lumen in A, and demonstrating actual site of ﬁstula between distal
ileum and UB lumen in (B)
514 A.H. Aﬁﬁ, M.I. Kassemwith negative CT enterography underwent two ileoscopies, all
of which were negative. At follow-up, the patient was asymp-
tomatic and stable. Correlated and uncorrelated Symptoms
with CT Enterography are shown in Table 2.
4. Discussion
Although Crohn’s disease has a low associated mortality rate,
patients with Crohn’s disease have signiﬁcant morbidity, re-
lated to the potential for serious complications. Because no ter-
minal cure exists for Crohn’s disease, the goals of therapy are
to maintain remission, minimize symptoms, and limit disease
progression (10,11). The early treatment in patients with a re-
lapse with follow up for the response to treatment results in
minimization of disease complications (12).
CT enterography is a relatively new imaging technique that
combines the improved spatial and temporal resolution of
MDCT with large amounts of ingested neutral contrast mate-rial. Unlike routine CT, which uses high-density oral contrast
material, CT enterography uses neutral oral contrast material
as water combined with mannitol, allowing bowel distention
and detection of the abnormal mucosal enhancement that is
one of the hallmarks of Crohn’s disease (13,14).
Both types of endoscopy (capsule endoscopy and ileoscopy)
depicted early or mild mucosal ﬁndings of small-bowel Cro-
hn’s disease than did CT enterography. (15) The beneﬁt of
CT enterography becomes more appreciable in patients with
more advanced Crohn’s disease who cannot undergo capsule
endoscopy, because CT enterography can depict and facilitate
the evaluation of complications as obstructions, ﬁstulas, and
abscess formations (16,17).
CT enterography is considered as a faster, more comfort-
able, and more sensitive technique than a barium examination
in these patients. In addition, for patients in whom ileoscopy
was unsuccessful, CT enterography may be used to rule out
a stricture or obstruction before capsule endoscopy is per-
formed. In fact, CT is now commonly used to rule out
small-bowel obstruction in many clinical situations (18).
In clinical practice, patients can undergo initial evaluation
with CT enterography to diagnose or exclude Crohn’s disease
and help determine whether surgical intervention is necessary
or not.
CT enterography, similar to SBFT and enteroclysis, has a
high sensitivity for diagnosing strictures. A stricture due to
acute disease, manifested by bowel wall hyperenhancement,
thickening, and mural stratiﬁcation, is usually treated medi-
cally. Lack of enhancement and loss of stratiﬁcation suggests
transmural ﬁbrosis and may require surgical intervention (19).
Wireless capsule endoscopy is contraindicated when stric-
tures with a luminal diameter of <1 cm are present. CT enter-
ography, therefore, assumes an important primary role in the
identiﬁcation of the small bowel strictures (20).
Hara and colleagues (21) observed that CT enterography
ﬁndings positively correlated with disease progression or
regression. Colombel and colleagues (22) demonstrated that
the perienteric ﬁndings of inﬂammation on CT enterography
correlate with the levels of C reactive protein, a marker of dis-
ease activity.
Lee and colleagues (23) observed that when the ‘‘comb’’
sign is present, the patients were more likely to be admitted
to the hospital and to receive aggressive treatment.
Voderholzer and colleagues (24) in a prospective compari-
son of wireless capsule endoscopy and CT enteroclysis, could
not evaluate 27% of their patients with wireless capsule endos-
copy because of strictures identiﬁed on CT enteroclysis. How-
ever, wireless capsule endoscopy has high sensitivity when mild
mucosal abnormalities are present and may be useful in the
assessment of Crohn’s disease when both ileocolonoscopy
and CT enterography are normal.
CT has an established role in the evaluation of extraenteric
complications of Crohn’s disease. The most common extraen-
teric complications include ﬁstula, sinus tract, abscess and ﬂeg-
mon (25).
CT enterography has a high sensitivity for diagnosing ﬁstu-
lae. A recent study demonstrated that CT enterography cor-
rectly identiﬁes the presence or absence of ﬁstulae in 94% of
patients. Multiplanar reformations are particularly useful for
detecting ﬁstulae. CT enterography can detect clinically unsus-
pected ﬁstulae or even early adhesions, resulting in changes in
the treatment regimen (26).
Fig. 9 A thirty-two-year-old female patient presented with attacks of adhesive intestinal obstruction and anemia, (A) axial enhanced CT
revealed adhesions and ﬁstula between distal ileum (with thick enhancing mucosa) and adjacent sigmoid colon. (B, C) Surgical specimens
reveal Crohn’s disease of the ileum and left colon (arrow, site of ileocolic ﬁstula).
Fig. 10 Coronal CT image revealed large abscess involving right
iliacus muscle, extending into upper thigh with its origin in right
iliac fossa complicating Crohn’s disease. Note: Associated thick
enhancing bowel wall denoting active disease
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as mesenteric lymphadenopathy, cholelithiasis, nephrolitiasis,
sacroiliitis, and primary sclerosing cholangitis, can also be
evaluated (27).
In our study, Fifty CT enterography examinations in 25 pa-
tients with known or suspected Crohn’s disease were retrospec-
tively evaluated by a radiologist who was blinded to the
clinical history. Disease progression or regression by CT enter-
ography correlated with symptoms in 20 of 25 (80%) patients.
CT enterography and symptoms agreed in 15 patients with
clinical disease progression, three patients with clinical regres-
sion, and two with clinically stable disease. In ﬁve of 25 (20%)
patients, symptoms progressed although CT ﬁndings were im-
proved (n= 4) and negative (n= 1).
Eight patients subsequently underwent surgery with a mean
time between CT and surgery of 18.4 days and a median of
21 days. Patients were subsequently treated surgically for Cro-
hn’s disease with an improvement in symptoms (n= 2), and
worsening of symptoms were due to Crohn’s disease (n= 6)
and not to a functional or non–Crohn’s disease cause.
In our study, the ability of CT enterography to prove or ex-
clude the presence of active Crohn’s disease was high and cor-
related well with worsening symptoms. Therefore, in our
study, it appears that CT enterography is an accurate test to
determine whether worsening symptoms are due to Crohn’s
disease.
CT enterography is more widely available, cheaper, and
faster, 20-s scanning time compared with 30 min needed to per-
form MR enterography (28,29).
In comparison with endoscopy, our ﬁndings suggest that
CT enterography ﬁndings provide better correlation with
endoscopically active disease than patient symptoms provide.
Table 2 Changes in Symptoms, CT Enterography Findings, Treatment, and follow-Up.
Symptoms CT enterography (No of pat. = 25) Treatment Follow up
Symptoms Correlated with
CT Enterography (n= 20):
No change No change 2 Stable (2) Stable
Worse Worse 15 Medical treatment (5) Improved
Surgery (7) Improved
Drainage (3)
Improved Improved 3 Regression (3) Improved
Symptoms uncorrelated with
CT Enterography (n= 5):
Worse Negative 1 No change (1) Stable
Worse Improved 4 Surgery (1) Improved
Stable (3) Stable
Fig. 11 Axial CT with contrast ﬁlling UB revealed large
phlegmon extending from right iliac fossa, adherent and penetrat-
ing anterior wall of UB
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(24/25, 96% i.e., positive endoscopy ﬁndings of Crohn’s dis-
ease and positive CT enterography ﬁndings of Crohn’s dis-
ease). Also endoscopic ﬁndings correlated with symptoms in
all cases (25/25,100%).
Larger studies have also shown that ﬁndings of Crohn’s dis-
ease at CT enterography correlate highly with endoscopy. For
example, in a study of 96 patients who underwent CT enterog-
raphy and ileoscopy, bowel wall thickening and enhancement
on CT enterography correlated signiﬁcantly (p< 0.001) with
ileoscopic and histologic ﬁndings of active Crohn’s disease (1).
The main limitations of our study are the small number of
patients (small sample size, which precluded any ﬁndings of
statistical signiﬁcance), difﬁcult ileal intubation especially with
strictures due to complicated Crohn’s disease, a reliable refer-
ence standard for diagnosing Crohn’s disease proximal to the
terminal ileum is difﬁcult, and its retrospective nature, this
study is also at risk for selection bias because patients with
worsening symptoms would be more likely to have more CT
enterography than patients who improved or stable patients.
5. Conclusion
This study concluded that CT enterography examinations per-
formed with water as oral contrast material may be useful formonitoring Crohn’s disease progression or regression. CT
enterography is better for assessing and detecting transmural
and extramural abnormalities of Crohn’s disease.
The presence of CT criteria for active disease (i.e., mucosal
hyperenhancement, mural stratiﬁcation, or mesenteric fat
stranding) was a good predictor of active small bowel disease
at ileoscopy. In addition, small-bowel CT enterography ﬁnd-
ings correlated well with ileoscopy in the patients and helped
to assess for complications and treatment of Crohn’s disease.
In the future, the evaluation of this technique in a larger group
of patients suspected of Crohn disease is warranted.
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